compared the expression of immune checkpoint molecules, such as PD-L1, PD-1, and TIM-3, in Hodgkin lymphoma and DLBCL using imaging mass cytometry and single-cell spatial analysis. The gene discussed is HAVCR2; the disease is diffuse large B-cell lymphoma.